Daniel Skubleny

MD, PhD. General Surgery Resident at the University of Alberta!

[Daniel Skubleny @Daniel_Skubleny]

Read my latest #research titled "Uncovering Global Trends in Surgical Oncology Trials: Applying Natural Language Processing to https://t.co/m6S2VwxSyC", published in @AnnSurgOncol https://t.co/yisvkxDj29

[Daniel Skubleny @Daniel_Skubleny]

Super excited to learn from the amazing UBC Surgical Oncology group for fellowship starting in July 2025! #UBC #CGSO @ubcgensurg @Ecosurgeon

[Daniel Skubleny @Daniel_Skubleny]

In this study we evaluated two methods for normalization between microarray and RNAseq data. Both FSQN and FSMVN delivered equivalent performance. Check it out here in @BMCBioinfo! https://t.co/0vio08CsOz

[Daniel Skubleny @Daniel_Skubleny]

Here, we demonstrate the accuracy and utility of individual survival distributions using the PanCancer Atlas. ISDs possess many advantages over traditional survival prediction techniques such as nomograms. Check it out! #machinelearning #CancerResearch

https://t.co/4qgz8NOwaO

[Daniel Skubleny @Daniel_Skubleny]

We conducted a pilot study that demonstrated the utility of the CD4/CD8 ratio in predicting treatment response to neoadjuvant FLOT chemotherapy in gastric cancer.
#cancer #Immunology

https://t.co/2goGeHyWEq

[Daniel Skubleny @Daniel_Skubleny]

@BradleyNori I caved. #mentorship

[Daniel Skubleny @Daniel_Skubleny]

Method to expand the procurement of tissue for patient-derived organoids.
Murine and Human Gastric Tissue Establishes Organoids after 48 Hours of Cold Ischemia Time during Shipment. #personalizedmedicine #organoid
https://t.co/j0N8KYuLQF